470 related articles for article (PubMed ID: 32321084)
1. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
2. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D.
Gellad WF; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Mor M; Hale JA; Radomski T; Hausmann LR; Fine MJ; Good CB
Subst Abus; 2017; 38(1):22-25. PubMed ID: 27925868
[TBL] [Abstract][Full Text] [Related]
3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
4. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
[No Abstract] [Full Text] [Related]
5. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
Guy GP; Zhang K; Halpin J; Sargent W
Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
[TBL] [Abstract][Full Text] [Related]
7. An examination of opioid prescription for Medicare Part D patients among family practice prescribers.
Pan K; Blankley AI; Hughes PJ
Fam Pract; 2019 Jul; 36(4):467-472. PubMed ID: 30239656
[TBL] [Abstract][Full Text] [Related]
8. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.
Carico R; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Suda KJ; Stroupe K; Hanlon JT; Good CB; Fine MJ; Gellad WF
Ann Intern Med; 2018 Nov; 169(9):593-601. PubMed ID: 30304353
[TBL] [Abstract][Full Text] [Related]
9. Polydrug epidemiology: Benzodiazepine prescribing and the drug overdose epidemic in the United States.
Zoorob MJ
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):541-549. PubMed ID: 29537112
[TBL] [Abstract][Full Text] [Related]
10. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
11. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
Jones CM; Compton W; Vythilingam M; Giroir B
JAMA; 2019 Aug; 322(5):462-464. PubMed ID: 31386124
[TBL] [Abstract][Full Text] [Related]
12. State variation in opioid and benzodiazepine prescriptions between independent and nonindependent advanced practice registered nurse prescribing states.
Schirle L; McCabe BE
Nurs Outlook; 2016; 64(1):86-93. PubMed ID: 26712387
[TBL] [Abstract][Full Text] [Related]
13. Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.
Schuler MS; Dick AW; Gordon AJ; Saloner B; Kerber R; Stein BD
Drug Alcohol Depend; 2024 Jun; 259():111290. PubMed ID: 38678682
[TBL] [Abstract][Full Text] [Related]
14. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
15. Patterns in Outpatient Benzodiazepine Prescribing in the United States.
Agarwal SD; Landon BE
JAMA Netw Open; 2019 Jan; 2(1):e187399. PubMed ID: 30681713
[TBL] [Abstract][Full Text] [Related]
16. Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021.
Larochelle MR; Jones CM; Zhang K
Drug Alcohol Depend; 2023 Jul; 248():109933. PubMed ID: 37267746
[TBL] [Abstract][Full Text] [Related]
17. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.
Moyo P; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Donohue JM; Hausmann LRM; Hanlon JT; Good CB; Fine MJ; Gellad WF
Ann Intern Med; 2019 Apr; 170(7):433-442. PubMed ID: 30856660
[TBL] [Abstract][Full Text] [Related]
18. Prescribing of Opioids and Benzodiazepines Among Patients With History of Overdose.
Griggs C; Wyatt S; Wally MK; Runyon M; Hsu JR; Seymour RB; Beuhler M; Bosse MJ; Fogg R; Gibbs M; Haas E; Jarrett S; Leas D; Saha A; Schiro S; Watling B;
J Addict Med; 2019; 13(5):396-402. PubMed ID: 30844876
[TBL] [Abstract][Full Text] [Related]
19. Opioid prescribing patterns among otolaryngologists: Crucial insights among the medicare population.
Svider PF; Arianpour K; Guo E; Folbe E; Zuliani G; Lin H; Eloy JA; Folbe AJ
Laryngoscope; 2018 Jul; 128(7):1576-1581. PubMed ID: 29446449
[TBL] [Abstract][Full Text] [Related]
20. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
